{
    "paper_id": "4f9854e6434f613ed77839a7d1b38ca4c5059d7b",
    "metadata": {
        "title": "Supplementary Appendix",
        "authors": []
    },
    "abstract": [],
    "body_text": [
        {
            "text": "This was an observational study that recruited children and adolescents confirmed to have severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection treated at the Wuhan Children's Hospital located in Wuhan, the epidemic center of this novel infection. The Wuhan",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Study Design and Participants"
        },
        {
            "text": "Children's Hospital is the only designated hospital for treating patients under 16 years of age with SARS-CoV-2 infection in Wuhan assigned by the central government. Children with known contact with individuals having confirmed or suspected SARS-CoV-2 infection would undergo confirmatory testing. All the children tested positive for SAR-CoV-2 were recruited in this study.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Study Design and Participants"
        },
        {
            "text": "This study included children presented to our hospital between January 28 to February 26, 2020.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Study Design and Participants"
        },
        {
            "text": "The natural history and clinical outcomes were monitored up to March 8, 2020. This study was approved by the institutional ethics board of the Wuhan Children's Hospital (Approval number WHCH 2020003). Informed consent was obtained from parents or legal guardian of each patient.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Study Design and Participants"
        },
        {
            "text": "Data from the medical records were extracted by members of the research team and were checked by two independent researchers. Epidemiological data were collected through interviews with the patients, their parents and legal guardians. Clinical presentation, comorbidities, laboratory results, radiological findings including chest radiographs and computed tomographic (CT) scans, modalities of treatment (oxygen therapy, intensive care support, use of antiviral or antibacterial agents) and outcomes were extracted from the medical records and entered into our clinical record form for subsequent analyses.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Data Collection"
        },
        {
            "text": "Nasopharyngeal swabs from suspected children younger than 2 years of age and throat swabs from children 2 years or older were obtained for detection of SAR-CoV-2 RNA. After collection, the swabs were transported to the laboratory within 2 hours in a collection tube with 150 microliter virus preservative medium. RNA from the respiratory specimens was extracted with the High Pure Viral Nucleic Acid Kit (Zhongzhi, Wuhan, China). The extracted nucleic acids were tested for SAR-CoV-2 using real-time reverse transcription polymerase chain reaction (RT-PCR) assay as described previously. 1, 2 In brief, the following sequences of SARS-CoV-2 were adopted for the RT-PCR assays: forward primer 5\u2032-TCAGAATGCCAATCTCCCCAAC-3\u2032; reverse primer 5\u2032-AAAGGTCCACCCGATACATTGA-3\u2032; probe 5\u2032CY5-CTAGTTACACTAGCCATCCTTACTGC-3\u2032BHQ1.",
            "cite_spans": [
                {
                    "start": 588,
                    "end": 590,
                    "text": "1,",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 591,
                    "end": 592,
                    "text": "2",
                    "ref_id": "BIBREF1"
                }
            ],
            "ref_spans": [],
            "section": "Real-Time Reverse Transcription Polymerase Chain Reaction Assay for SARS-CoV-2"
        },
        {
            "text": "Amplifications were initially done at 50\u00b0C for 15 min and subsequently at 95\u00b0C for 3 min, followed by 45 cycles of 95\u00b0C for 15 s and 60\u00b0C for 30 s.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Real-Time Reverse Transcription Polymerase Chain Reaction Assay for SARS-CoV-2"
        },
        {
            "text": "The age distribution of patients and their respective diagnoses (asymptomatic infection, upper respiratory tract infection, pneumonia) were summarized in Table S1 . The median ages of asymptomatic patients, patients with upper respiratory infections (URTI), and patients with pneumonia were 9.6, 3.9, and 5.9 years, respectively. The laboratory results of all children were summarized in Table S2 . Laboratory results were expressed as median (interquartile range) or n (%). The 6 (3.5%) patients with lymphopenia either had URTI or pneumonia. Figure S1 shows abnormalities of the chest CT images from representative patients. Representative chest CT scan images from patients with different severity of the infection. Bilateral ground glass opacities in a thirteen-month old boy with severe pneumonia requiring ICU care (A, B). Chest CT scan image from a 14-year old girl showing basal infiltrates (C). Chest CT scan image from a 15-year old asymptomatic boy showing ground glass opacity in the right posterior lung field.",
            "cite_spans": [],
            "ref_spans": [
                {
                    "start": 154,
                    "end": 162,
                    "text": "Table S1",
                    "ref_id": "TABREF1"
                },
                {
                    "start": 388,
                    "end": 396,
                    "text": "Table S2",
                    "ref_id": null
                },
                {
                    "start": 544,
                    "end": 553,
                    "text": "Figure S1",
                    "ref_id": "FIGREF0"
                }
            ],
            "section": "Results"
        }
    ],
    "bib_entries": {
        "BIBREF0": {
            "ref_id": "b0",
            "title": "National Institute For Viral Disease Control and Prevention",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        },
        "BIBREF1": {
            "ref_id": "b1",
            "title": "World Health Organization-Novel Coronavirus (2019-nCoV",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "Chest CT scan images of representative patients\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.interests\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026......8 References\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026..... 8",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "urea nitrogen (mmol/L; 2.9-7.1) 4.1 (3.3-4.8) 4.7 (3.6-5.5) 4.1 (3.4-4.4) 4.1 (3.1-4.8) Procalcitonin was available from 164 patients (25 patients with asymptomatic infection, 32 patients with upper respiratory tract infection, 107 patients with pneumonia) #D-dimer was available from 149 patients (27 patients with asymptomatic infection, 25 patients with upper respiratory tract infections and 97 patients with pneumonia.",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Chest CT scan images of representative patients.",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "Methods\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.... 2 Age distribution of infected children and their respective diagnoses\u2026\u2026.. 4 Laboratory results of 171 infected children and their respective diagnoses 5",
            "latex": null,
            "type": "table"
        },
        "TABREF1": {
            "text": "Age distribution of infected children and their respective diagnosesTable S2. Laboratory results of 171 infected children and their respective diagnoses",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": "We are very grateful to all the medical, nursing and supportive staff of the Wuhan Children's Hospital for their dedication in looking after the patients during this epidemic.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Acknowledgement"
        },
        {
            "text": "The authors have no competing interests to declare.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Declaration of interests"
        },
        {
            "text": "XL, GW, KS, and SX conceptualized the study design. XL, JZ, YYL, DL, HD, JS, GW, and SX analysed the data with input from JS, XP, YY, ZL, YX, YW, FZ, SB, LZ, HX, YL, CW, JQ, WZ, HL, YY. XL, JZ, GW wrote the first draft with all authors providing critical feedback for subsequent revisions of the manuscript. All authors read and approved the final report.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Author Contributions"
        }
    ]
}